Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Borghetti

Showing results (161-170 of 162) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 162 results.
The Journal of Antimicrobial Chemotherapy|May 6, 2016
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapyA Borghetti, G Baldin, A Ciccullo, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIVA Borghetti, A Calcagno, F Lombardi, et al.
Pageof 17

Showing results (161-170 of 162) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 162 results.
The Journal of Antimicrobial Chemotherapy|May 6, 2016
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapyA Borghetti, G Baldin, A Ciccullo, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIVA Borghetti, A Calcagno, F Lombardi, et al.
Pageof 17